Cargando…

Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study

BACKGROUND: Determining the risk of Cardiovascular Disease (CVD) is a necessity for timely preventive interventions in high-risk groups. However, laboratory testing may be impractical in countries with limited resources. This study aimed at comparison and assessment of the agreement between laborato...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Fatemeh, Seif, Mozhgan, Gandomkar, Abdullah, Fattahi, Mohammad Reza, Malekzadeh, Fatemeh, Sepanlou, Sadaf G., Hasanzadeh, Jafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925162/
https://www.ncbi.nlm.nih.gov/pubmed/35296342
http://dx.doi.org/10.1186/s12967-022-03336-4
_version_ 1784670011298676736
author Rezaei, Fatemeh
Seif, Mozhgan
Gandomkar, Abdullah
Fattahi, Mohammad Reza
Malekzadeh, Fatemeh
Sepanlou, Sadaf G.
Hasanzadeh, Jafar
author_facet Rezaei, Fatemeh
Seif, Mozhgan
Gandomkar, Abdullah
Fattahi, Mohammad Reza
Malekzadeh, Fatemeh
Sepanlou, Sadaf G.
Hasanzadeh, Jafar
author_sort Rezaei, Fatemeh
collection PubMed
description BACKGROUND: Determining the risk of Cardiovascular Disease (CVD) is a necessity for timely preventive interventions in high-risk groups. However, laboratory testing may be impractical in countries with limited resources. This study aimed at comparison and assessment of the agreement between laboratory-based and non-laboratory-based WHO risk charts models. METHODS: This study was performed using the baseline data of 8138 participants in the pars cohort study who had no history of CVD and stroke. The updated 2019 WHO model was used to determine the 10-year fatal and non-fatal CVD risks. In general, there are two types of new WHO risk prediction models for CVD. The scores were determined based on age, sex, smoking status, diabetes, Systolic Blood Pressure (SBP), and total cholesterol for the laboratory-based model and age, sex, smoking status, SBP, and Body Mass Index (BMI) for the non-laboratory-based model. The agreement of these two models was determined via kappa statistics for the classified risk (low: < 10%, moderate: 10–< 20%, high: ≥ 20%). Correlation coefficients (r) and scatter plots was used for correlation between scores. RESULTS: The results revealed very strong correlation coefficients for all sex and age groups (r = 0.84 for males < 60 years old, 0.93 for males ≥ 60 years old, 0.85 for females < 60 years old, and 0.88 for females ≥ 60 years old). In the laboratory-based model, low, moderate, and high risks were 76.10%, 18.17%, and 5.73%, respectively. These measures were respectively obtained as 77.00%, 18.08%, and 4.92% in the non-laboratory-based model. Based on risk classification, the agreement was substantial for males < 60 years old and for both males and females aged ≥ 60 years (kappa values: 0.79 for males < 60 years old, 0.65 for males ≥ 60 years old, and 0.66 for females ≥ 60 years old) and moderate for females < 60 years old (kappa = 0.46). CONCLUSIONS: The non-laboratory-based risk prediction model, which is simple, inexpensive, and non-invasive, classifies individuals almost identically to the laboratory-based model. Therefore, in countries with limited resources, these two models can be used interchangeably.
format Online
Article
Text
id pubmed-8925162
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89251622022-03-23 Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study Rezaei, Fatemeh Seif, Mozhgan Gandomkar, Abdullah Fattahi, Mohammad Reza Malekzadeh, Fatemeh Sepanlou, Sadaf G. Hasanzadeh, Jafar J Transl Med Research BACKGROUND: Determining the risk of Cardiovascular Disease (CVD) is a necessity for timely preventive interventions in high-risk groups. However, laboratory testing may be impractical in countries with limited resources. This study aimed at comparison and assessment of the agreement between laboratory-based and non-laboratory-based WHO risk charts models. METHODS: This study was performed using the baseline data of 8138 participants in the pars cohort study who had no history of CVD and stroke. The updated 2019 WHO model was used to determine the 10-year fatal and non-fatal CVD risks. In general, there are two types of new WHO risk prediction models for CVD. The scores were determined based on age, sex, smoking status, diabetes, Systolic Blood Pressure (SBP), and total cholesterol for the laboratory-based model and age, sex, smoking status, SBP, and Body Mass Index (BMI) for the non-laboratory-based model. The agreement of these two models was determined via kappa statistics for the classified risk (low: < 10%, moderate: 10–< 20%, high: ≥ 20%). Correlation coefficients (r) and scatter plots was used for correlation between scores. RESULTS: The results revealed very strong correlation coefficients for all sex and age groups (r = 0.84 for males < 60 years old, 0.93 for males ≥ 60 years old, 0.85 for females < 60 years old, and 0.88 for females ≥ 60 years old). In the laboratory-based model, low, moderate, and high risks were 76.10%, 18.17%, and 5.73%, respectively. These measures were respectively obtained as 77.00%, 18.08%, and 4.92% in the non-laboratory-based model. Based on risk classification, the agreement was substantial for males < 60 years old and for both males and females aged ≥ 60 years (kappa values: 0.79 for males < 60 years old, 0.65 for males ≥ 60 years old, and 0.66 for females ≥ 60 years old) and moderate for females < 60 years old (kappa = 0.46). CONCLUSIONS: The non-laboratory-based risk prediction model, which is simple, inexpensive, and non-invasive, classifies individuals almost identically to the laboratory-based model. Therefore, in countries with limited resources, these two models can be used interchangeably. BioMed Central 2022-03-16 /pmc/articles/PMC8925162/ /pubmed/35296342 http://dx.doi.org/10.1186/s12967-022-03336-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Rezaei, Fatemeh
Seif, Mozhgan
Gandomkar, Abdullah
Fattahi, Mohammad Reza
Malekzadeh, Fatemeh
Sepanlou, Sadaf G.
Hasanzadeh, Jafar
Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study
title Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study
title_full Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study
title_fullStr Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study
title_full_unstemmed Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study
title_short Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study
title_sort comparison of laboratory-based and non-laboratory-based who cardiovascular disease risk charts: a population-based study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925162/
https://www.ncbi.nlm.nih.gov/pubmed/35296342
http://dx.doi.org/10.1186/s12967-022-03336-4
work_keys_str_mv AT rezaeifatemeh comparisonoflaboratorybasedandnonlaboratorybasedwhocardiovasculardiseaseriskchartsapopulationbasedstudy
AT seifmozhgan comparisonoflaboratorybasedandnonlaboratorybasedwhocardiovasculardiseaseriskchartsapopulationbasedstudy
AT gandomkarabdullah comparisonoflaboratorybasedandnonlaboratorybasedwhocardiovasculardiseaseriskchartsapopulationbasedstudy
AT fattahimohammadreza comparisonoflaboratorybasedandnonlaboratorybasedwhocardiovasculardiseaseriskchartsapopulationbasedstudy
AT malekzadehfatemeh comparisonoflaboratorybasedandnonlaboratorybasedwhocardiovasculardiseaseriskchartsapopulationbasedstudy
AT sepanlousadafg comparisonoflaboratorybasedandnonlaboratorybasedwhocardiovasculardiseaseriskchartsapopulationbasedstudy
AT hasanzadehjafar comparisonoflaboratorybasedandnonlaboratorybasedwhocardiovasculardiseaseriskchartsapopulationbasedstudy